HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics: Pathological assessment of HER2 and appropriate testing methodologies (0:00) Effect of the DESTINY-Breast04 study on clinical practice (12:32) Relevancy of HER2-ultralow expression and implications of the DESTINY-Breast06 study (22:53) Future directions in the pathological and clinical assessment of HER2-positive breast cancer (31:06) CME information and select publications